Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael L Hadley

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Atlas of the Oral and Maxillofacial Surgery Clinics of North America|April 6, 2004
A cosmetic approach to cutaneous defectsChristopher B Harmon, Michael L Hadley
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|November 21, 2008
Nonmelanoma skin cancers of the ear: correlation between subanatomic location and post-Mohs micrographic surgery defect sizeKeith L Duffy, Jeffrey K McKenna, Michael L Hadley, et al.
Archives of Dermatology|March 21, 2012
A randomized trial of the off-label use of imiquimod, 5%, cream with vs without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisionsMark A Hyde, Michael L Hadley, Payam Tristani-Firouzi, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|June 13, 2015
Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic centerTracie Chong, Payam Tristani-Firouzi, Glen M Bowen, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|October 22, 2010
Use of physician assistants in Mohs micrographic surgery: a survey of fellowship-trained Mohs micrographic surgeonsMark A Hyde, Michael L Hadley, Conrad Roberson, et al.
JAMA Dermatology|May 31, 2018
Rate of Recurrence of Lentigo Maligna Treated With Off-Label Neoadjuvant Topical Imiquimod, 5%, Cream Prior to Conservatively Staged ExcisionJessica M Donigan, Mark A Hyde, David E Goldgar, et al.
Journal of the American Academy of Dermatology|January 3, 2009
Androgen receptor expression patterns in Becker's nevi: an immunohistochemical studyHege Grande Sarpa, Ronald Harris, C David Hansen, et al.
Journal of Cutaneous Pathology|October 13, 2016
Cutaneous carcinosarcoma: a series of six cases and a review of the literatureJoshua J Clark, Anneli R Bowen, Glen M Bowen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Atlas of the Oral and Maxillofacial Surgery Clinics of North America|April 6, 2004
A cosmetic approach to cutaneous defectsChristopher B Harmon, Michael L Hadley
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|November 21, 2008
Nonmelanoma skin cancers of the ear: correlation between subanatomic location and post-Mohs micrographic surgery defect sizeKeith L Duffy, Jeffrey K McKenna, Michael L Hadley, et al.
Archives of Dermatology|March 21, 2012
A randomized trial of the off-label use of imiquimod, 5%, cream with vs without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisionsMark A Hyde, Michael L Hadley, Payam Tristani-Firouzi, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|June 13, 2015
Mohs appropriate use criteria: retrospectively applied to nonmelanoma skin cancers at a single academic centerTracie Chong, Payam Tristani-Firouzi, Glen M Bowen, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|October 22, 2010
Use of physician assistants in Mohs micrographic surgery: a survey of fellowship-trained Mohs micrographic surgeonsMark A Hyde, Michael L Hadley, Conrad Roberson, et al.
JAMA Dermatology|May 31, 2018
Rate of Recurrence of Lentigo Maligna Treated With Off-Label Neoadjuvant Topical Imiquimod, 5%, Cream Prior to Conservatively Staged ExcisionJessica M Donigan, Mark A Hyde, David E Goldgar, et al.
Journal of the American Academy of Dermatology|January 3, 2009
Androgen receptor expression patterns in Becker's nevi: an immunohistochemical studyHege Grande Sarpa, Ronald Harris, C David Hansen, et al.
Journal of Cutaneous Pathology|October 13, 2016
Cutaneous carcinosarcoma: a series of six cases and a review of the literatureJoshua J Clark, Anneli R Bowen, Glen M Bowen, et al.
Pageof 1